• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植血管病变:内皮损伤导致移植“动脉粥样瘤”的核心作用。

Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma".

作者信息

Valantine Hannah A

机构信息

Falk Cardiovascular Research Center, Stanford University, California 94305-5406, USA.

出版信息

Transplantation. 2003 Sep 27;76(6):891-9. doi: 10.1097/01.TP.0000080981.90718.EB.

DOI:10.1097/01.TP.0000080981.90718.EB
PMID:14508350
Abstract

Endothelial injury plays a central role in the pathophysiologic mechanisms underlying cardiac allograft vasculopathy (CAV). Although the accelerated course of CAV and its localization to the allograft support an important role for the alloimmune response, there is considerable evidence implicating lipoprotein abnormalities, metabolic disturbances, viral infections, and systemic inflammation in the process. This multifactorial basis for CAV may be put into a pathophysiologic context in which endothelial cell injury is the triggering event that initiates and drives the proliferative and fibrotic processes characteristic of CAV. In the transplant setting, endothelial cell injury is induced by multiple factors, including brain death, ischemia-reperfusion, alloimmune responses, and viral infections. Once initiated, propagation of the proliferative processes that ultimately lead to vascular occlusion is enhanced by the abnormal metabolic environment of elevated lipoproteins and insulin resistance encountered in most patients. This review examines the evidence for the role of potential triggers of endothelial injury in the pathophysiology of CAV and discusses the central role of the nitric oxide pathway in the disease process.

摘要

内皮损伤在心脏移植血管病变(CAV)的病理生理机制中起核心作用。尽管CAV的加速病程及其在移植心脏中的定位表明同种异体免疫反应起重要作用,但有大量证据表明脂蛋白异常、代谢紊乱、病毒感染和全身炎症在此过程中也有牵连。CAV的这种多因素基础可能被置于一种病理生理背景中,其中内皮细胞损伤是引发并驱动CAV特征性增殖和纤维化过程的触发事件。在移植环境中,内皮细胞损伤由多种因素诱导,包括脑死亡、缺血再灌注、同种异体免疫反应和病毒感染。一旦启动,大多数患者所遇到的脂蛋白升高和胰岛素抵抗的异常代谢环境会增强最终导致血管闭塞的增殖过程的传播。本综述探讨了内皮损伤潜在触发因素在CAV病理生理学中作用的证据,并讨论了一氧化氮途径在疾病过程中的核心作用。

相似文献

1
Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma".心脏移植血管病变:内皮损伤导致移植“动脉粥样瘤”的核心作用。
Transplantation. 2003 Sep 27;76(6):891-9. doi: 10.1097/01.TP.0000080981.90718.EB.
2
Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury.
J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 2):S142-9.
3
Cardiac allograft vasculopathy: recent developments.心脏移植血管病变:近期进展
Circulation. 2008 Apr 22;117(16):2131-41. doi: 10.1161/CIRCULATIONAHA.107.711911.
4
Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.迟发性抗体介导的排斥反应和血管内皮生长因子的内皮定位与心脏移植血管病变的发生有关。
Transplantation. 2008 Oct 15;86(7):991-7. doi: 10.1097/TP.0b013e318186d734.
5
Treatment and prophylaxis of cardiac allograft vasculopathy.心脏移植血管病变的治疗与预防
Transplant Proc. 2008 Oct;40(8):2609-10. doi: 10.1016/j.transproceed.2008.08.073.
6
Allograft vasculopathy versus atherosclerosis.同种异体移植血管病变与动脉粥样硬化
Circ Res. 2006 Oct 13;99(8):801-15. doi: 10.1161/01.RES.0000246086.93555.f3.
7
Transplant vascular disease: role of lipids and proteoglycans.移植血管疾病:脂质与蛋白聚糖的作用
Can J Cardiol. 2004 Aug;20 Suppl B:58B-65B.
8
The continuing challenge of cardiac transplant arteriosclerosis.心脏移植后动脉硬化的持续挑战。
Cardiologia. 1998 Aug;43(8):777-87.
9
Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.尿酸水平升高可预测心脏移植受者的移植血管病变。
J Heart Lung Transplant. 2007 May;26(5):498-503. doi: 10.1016/j.healun.2007.01.039.
10
Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.心脏移植受者的巨细胞病毒感染与内皮功能受损有关。
Circulation. 2004 Sep 14;110(11 Suppl 1):II207-12. doi: 10.1161/01.CIR.0000138393.99310.1c.

引用本文的文献

1
Revisiting Biomarkers of Cardiac Allograft Vasculopathy: Addressing the Achilles Heel of Heart Transplantation.重新审视心脏移植后移植物血管病的生物标志物:直击心脏移植的阿喀琉斯之踵。
Curr Heart Fail Rep. 2024 Dec;21(6):580-590. doi: 10.1007/s11897-024-00685-7. Epub 2024 Oct 17.
2
Obliterative foam-cell arteriopathy. A unifying concept embracing several entities previously described as radiation, decidual, transplant, and intratumoral-associated arteriopathy.闭塞性泡沫细胞动脉炎。一个统一的概念,包含了以前描述的几种实体,如放射、蜕膜、移植和肿瘤内相关动脉炎。
Rom J Morphol Embryol. 2023 Oct-Dec;64(4):457-466. doi: 10.47162/RJME.64.4.01.
3
Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy.
用于减轻同种异体抗原呈递和预防移植血管病变的免疫工程化MXene纳米系统。
Nano Today. 2023 Feb;48:None. doi: 10.1016/j.nantod.2022.101706.
4
Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19.COVID-19 病史的原位心脏移植受者发生加速性心脏移植物血管病。
Am J Case Rep. 2023 Mar 1;24:e937955. doi: 10.12659/AJCR.937955.
5
Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction.心脏死亡后供体心脏灌注期间使用细胞因子吸附器可对抗冠状动脉微血管功能障碍。
Antioxidants (Basel). 2022 Nov 17;11(11):2280. doi: 10.3390/antiox11112280.
6
Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography.利用光学相干断层扫描技术分析长期心脏移植患者血管造影显示的心脏移植血管病变中的纤维化斑块
Transplant Direct. 2021 Dec 23;8(1):e1266. doi: 10.1097/TXD.0000000000001266. eCollection 2022 Jan.
7
M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.M2 巨噬细胞在慢性移植排斥反应中的固有免疫中充当关键执行者。
Front Immunol. 2021 Mar 17;12:648539. doi: 10.3389/fimmu.2021.648539. eCollection 2021.
8
The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy.光学相干断层扫描及其他血管内成像方式在心脏移植血管病变中的作用
Postepy Kardiol Interwencyjnej. 2020 Mar;16(1):19-29. doi: 10.5114/aic.2020.93909. Epub 2020 Apr 3.
9
AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts.腺相关病毒介导的AP-1中和性RNA诱饵寡核苷酸表达减轻小鼠主动脉同种异体移植中的移植血管病。
Mol Ther Methods Clin Dev. 2019 Oct 2;15:246-256. doi: 10.1016/j.omtm.2019.09.009. eCollection 2019 Dec 13.
10
Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation.二甲双胍治疗糖尿病患者与心脏移植后血管病变和心血管死亡率降低相关。
Cardiovasc Diabetol. 2019 Sep 16;18(1):118. doi: 10.1186/s12933-019-0925-y.